![](https://investorshub.advfn.com/uicon/430424.png?cb=1554906782)
Monday, January 27, 2014 5:05:47 PM
*I learned something that gave me a bit more confidence in the market. As Ou stated, there is no wiggle room regarding the Fair Disclosure Act.
* NWBO strongly reaffirmed their need to expand manufacturing, production and distribution. They reemphasized this is a large scale increase.
* FatCatBanker's prediction was unusually accurate.
* Beyond giving FCB his due, maintaining a closing price at or above $5.00 makes it easier for large institutions to get in near the ground floor.
* NWBO only wanted Marnix Bosch to speak about the Direct program today. I can see why. Had Marnix entertained questions regarding DCVAX-L today, with the way the case study session was written up in the conference's pre-announcement, Marnix would have been walking into a minefield. Without the DMC recommendation on DCVAX-L coming in yet, and without speaking to the FDA after any such DMC recommendation; any discussion may have seemed more like an attempt to share otherwise off-limit information. I think this measure of caution was warranted.
* NWBO held some gains today when the rest of the market saw mostly red.
* No DCVAX-L recommendation from the DMC, which tells me, IMHO, that the "large scale expansion" emphasis was not based upon any (otherwise unknown) DMC results.
* The Direct and L data is still in front of us. The time is close at hand.
Recent NWBO News
- Biophma Announces Exclusive In License for Dendritic Cell Technology, Sending Shares Higher • AllPennyStocks.com • 06/17/2024 04:40:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/04/2024 09:11:16 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 06/03/2024 09:22:55 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 05/22/2024 08:13:36 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/10/2024 09:04:57 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/01/2024 10:04:38 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/02/2023 01:31:35 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/16/2023 10:11:54 PM
- Epazz, Inc. (OTC Pink: EPAZ) ZenaDrone Demonstration to Defense Departments of UAE and Saudi Arabia • InvestorsHub NewsWire • 11/15/2023 12:19:31 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/09/2023 09:30:39 PM
- Epazz, Inc. (OTC Pink: EPAZ) US Navy Collaboration ZenaDrone 1000 • InvestorsHub NewsWire • 11/09/2023 01:00:34 PM
- Epazz, Inc. (OTC Pink: EPAZ) US Navy Collaboration ZenaDrone 1000 Extreme Weather Demo • InvestorsHub NewsWire • 11/07/2023 12:29:43 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/09/2023 08:36:14 PM
Last Shot Hydration Drink Announced as Official Sponsor of Red River Athletic Conference • EQLB • Jun 20, 2024 2:38 PM
ATWEC Announces Major Acquisition and Lays Out Strategic Growth Plans • ATWT • Jun 20, 2024 7:09 AM
North Bay Resources Announces Composite Assays of 0.53 and 0.44 Troy Ounces per Ton Gold in Trenches B + C at Fran Gold, British Columbia • NBRI • Jun 18, 2024 9:18 AM
VAYK Assembling New Management Team for $64 Billion Domestic Market • VAYK • Jun 18, 2024 9:00 AM
Fifty 1 Labs, Inc Announces Acquisition of Drago Knives, LLC • CAFI • Jun 18, 2024 8:45 AM
Hydromer Announces Attainment of ISO 13485 Certification • HYDI • Jun 17, 2024 9:22 AM